Rituximab Plus Chemotherapy Approved by FDA for Select Pediatric Cancers

Subtitle FDA approved rituximab in combination with chemotherapy for pediatric patients with previously untreated, advanced stage, CD20-positive DLBCL/BL/BLL/B-AL.